Benzinga - Wed, 24 Feb 2021 04:35:09 -0400
Benzinga - Tue, 19 Jan 2021 06:26:25 -0400
Benzinga - Mon, 11 Jan 2021 06:11:55 -0400
Benzinga - Thu, 07 Jan 2021 17:34:54 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Alimera Sciences Inc is a pharmaceutical company focused on commercializing and developing treatments that address diseases affecting the back of the eye (retina). ILUVIEN is Alimera's a patented micro-implant which delivers a continuous, low dose anti-inflammatory agent to the retina for up to 3 years. DME is often treated with acute therapies when the fluid in the eye returns. ILUVIEN reduces the recurrence of edema to stable vision, with the benefit of continuous treatment due to the product's novel drug delivery technology. The company expects to accelerate growth of ILUVIEN through increased penetration of existing markets; expansion into new markets; and a new indication for non-infectious posterior uveitis in the EU.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-04-28
REV
Q4 2020Est.ActualSurprise
EPS-0.040-0.180 -0.1400
REV13.430M13.774M344.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ALIMAlimera Sciences-11.57%45.5M

Alimera Sciences Company Questions & Answers

Q

How do I buy Alimera Sciences (ALIM) stock?

A

You can purchase shares of Alimera Sciences (NASDAQ: ALIM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Alimera Sciences's (ALIM) main competitors?

A

Other companies in Alimera Sciences’s space includes: Opiant Pharmaceuticals (NASDAQ:OPNT), Baudax Bio (NASDAQ:BXRX) and Cumberland (NASDAQ:CPIX).

Q

What is the target price for Alimera Sciences?

A

The latest price target for Alimera Sciences (NASDAQ: ALIM) was reported by H.C. Wainwright on 2020-04-14. The analyst firm set a price target for 14.00 expecting ALIM to rise to within 12 months (a possible 76.10% upside). 2 analyst firms have reported ratings in the last year.

Q

How much is Alimera Sciences (ALIM) stock ?

A

The stock price for Alimera Sciences (NASDAQ: ALIM) is $7.95 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Alimera Sciences (ALIM) dividend?

A

There are no upcoming dividends for Alimera Sciences.

Q

When is Alimera Sciences (NASDAQ:ALIM) reporting earnings?

A
Alimera Sciences’s Q1 earnings are confirmed after-market from now on April 28, 2021.
Q

When is the upcoming split for ALIM?

A

There is no upcoming split for Alimera Sciences.